Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & Exposition
Initial data from Phase 1 clinical trial of JSP191, a humanized antibody targeting CD117, to be presented today at 3:00…